Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
1.9%
1w
0.9%
1m
7.5%
3m
11.4%
6m
23.4%
1y
8.2%
all
16.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,470 1.9%
1,238
1,614
Company Overview
Sales
1,108 Cr
Growth: -8.7%
Profit after Tax
275 Cr
Growth: 5.5%
Mid Cap
15,375 Cr
P/E: 56.3x
Industry P/E: 34.2x
Fundamentals
Sales (Cr) ₹ 1,108
Growth -8.7%
EBITDA 35.0%
P/S 13.9x
Dividend 0.6%
P/E 56.3x
Book Value ₹ 198
PEG Ratio -6.3x
ROE 13.8%
P/B 7.1x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (24 Indices) view more
Followers (1)
varsha96